Basf Corporation v. United States, Defendant-Cross

482 F.3d 1324, 28 I.T.R.D. (BNA) 2473, 2007 U.S. App. LEXIS 7216
CourtCourt of Appeals for the Federal Circuit
DecidedMarch 29, 2007
Docket05-1477
StatusPublished
Cited by31 cases

This text of 482 F.3d 1324 (Basf Corporation v. United States, Defendant-Cross) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Basf Corporation v. United States, Defendant-Cross, 482 F.3d 1324, 28 I.T.R.D. (BNA) 2473, 2007 U.S. App. LEXIS 7216 (Fed. Cir. 2007).

Opinion

482 F.3d 1324

BASF CORPORATION, Plaintiff-Appellant,
v.
UNITED STATES, Defendant-Cross Appellant.

No. 05-1477.

No. 05-1523.

United States Court of Appeals, Federal Circuit.

March 29, 2007.

Frederic D. Van Arman, Jr., Barnes, Richardson & Colburn, of New York, NY, argued for plaintiff-appellant. With him on the brief was James S. O'Kelly. Of counsel was Helena D. Sullivan.

Jack S. Rockafellow, Attorney, Commercial Litigation Branch, Civil Division, United States Department of Justice, of New York, NY, argued for defendant-cross appellant. With him on the brief were Peter D. Keisler, Assistant Attorney General, David M. Cohen, Director, of Washington, DC, and Barbara S. Williams, Attorney in Charge, International Trade Field Office, United States Department of Justice, of New York, NY. Of counsel on the brief was Sheryl S. French, Office of Assistant Chief Counsel, International Trade Litigation, United States Customs and Board Protection, of New York, NY.

Erik D. Smithweiss, Grunfeld, Desiderio, Lebowitz, Silverman & Klestadt LLP, of New York, NY, for amici curiae Roche Vitamins, Inc. et al. With him on the brief was Joseph M. Spraragen.

Before NEWMAN, LOURIE, and RADER, Circuit Judges.

Opinion for the court filed by Circuit Judge NEWMAN.

PAULINE NEWMAN, Circuit Judge.

In this tariff classification case, both the importer BASF Corporation and the government appeal the decision of the United States Court of International Trade, holding that the imported product, brand name Lucarotin ® 1%, which contains 1% beta-carotene and is used as a food colorant, is classified under subheading 3204.19.35 ("Beta-carotene and other carotene coloring matter") of the Harmonized Tariff Schedule of the United States ("HTSUS").1 BASF argues that the product is entitled to duty-free treatment because beta-carotene is listed on the duty-free Pharmaceutical Appendix of the HTSUS. The Customs Service had initially classified and liquidated Lucarotin ® 1% under subheading 2106.90.99 ("Food preparations not elsewhere specified or included: Other"), but at trial and on this appeal the government proposes that 3204.19.40 ("Other") or 3204.19.50 ("Other") is the correct classification.

* The methodology of tariff classification is established by the HTSUS, which consists of the General Notes, the General Rules of Interpretation (GRI), and the Additional United States Rules of Interpretation (U.S.GRI), including all section and chapter notes and article provisions and the Chemical Appendix. The rules are applied in numerical order. See North American Processing Co. v. United States, 236 F.3d 695, 698 (Fed.Cir.2001); Baxter Healthcare Corp. of Puerto Rico v. United States, 182 F.3d 1333, 1337 (Fed.Cir.1999).

The HTSUS is a hierarchical classification system which requires application of the most specific descriptive category in determining the applicable duty. See General Elec. Co.-Medical Systems Group v. United States, 247 F.3d 1231, 1235 (Fed.Cir.2001) (the proper classification of merchandise according to the HTSUS requires looking to the most specific description and is preferred to headings of a more general description); Marubeni America Corp. v. United States, 35 F.3d 530, 536 (Fed.Cir.1994) ("under the General Rules of Interpretation (GRI) when an article satisfies the requirement of two provisions, it will be classified under the heading giving a more specific description"). When the name of the product and its use are included in an eo nomine2 description, that specific classification prevails over a more general classification of either name or use.

BASF states that the Court of International Trade erred in denying duty-free treatment, because beta-carotene is a provitamin and is listed on the Pharmaceutical Appendix. BASF argues that the purpose of the international agreement concerning duty-free movement of pharmaceuticals is to facilitate and encourage trade in such products, and therefore that they should be interpreted to include items such as Lucarotin ® 1%. BASF points out that beta-carotene is the only active component of Lucarotin ® 1% and argues that it is irrelevant, for tariff purposes, whether the beta-carotene is intended for pharmaceutical use or for some other purpose, stressing the listing of beta-carotene in the Pharmaceutical Appendix. BASF states that the court improperly incorporated an actual use requirement into the Pharmaceutical Appendix.

It is not disputed that the only active ingredient of Lucarotin ® 1% is its content of beta-carotene. Nor is it disputed that this product is not intended for vitamin or other pharmaceutical use, but is intended for use as a food colorant. The beta-carotene provides a strong redorange color, and the other ingredients are diluents, stabilizers, and dispersants. BASF's Technical Bulletin describes Lucarotin ® 1% as a food colorant containing "stabilized beta-carotene dispersed in soybean oil and embedded as minute droplets in a polysaccharide sugar matrix." The Court of International Trade applied the International Trade Commission's definition of a pharmaceutical product as "used in the prevention, diagnosis, alleviation, treatment, or cure of disease in humans or animals," Advice Concerning the Addition of Certain Pharmaceutical Products and Chemical Intermediates to the Pharmaceutical Appendix to the Harmonized Tariff Schedule of the United States, USITC Pub. 3167, at 3 (April 1999), and found, without dispute, that "[c]ustomers do not buy Lucarotin ® 1% for any purpose other than delivery of a beta-carotene colorant." Thus the court held that Lucarotin ® 1% is not eligible for duty-free importation despite the listing of beta-carotene on the Pharmaceutical Appendix.

When a product is specifically described or named (eo nomine) in the HTSUS, the specific classification prevails over any more general listing that also includes the imported product, as set forth in Rule 3 of the General Rules of Interpretation: GRI 3(a). The heading which provides the most specific description shall be preferred to headings providing a more general description. However, when two or more headings each refer to part of the materials or substances contained in mixed or composite goods or to part only of the items in a set put up for retail sale, those headings are to be regarded as equally specific in relation to those goods, even if one of them gives a more complete or precise description of the goods.

(b) Mixtures, composite goods consisting of different materials or made up of different components, and goods put up in sets for retail sale, which cannot be classified by reference to 3(a), shall be classified as if they consisted of the material or the component which gives them their essential character,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Keystone Auto. Operations, Inc. v. United States
2025 CIT 46 (Court of International Trade, 2025)
Kent Displays, Inc. v. United States
698 F. Supp. 3d 1339 (Court of International Trade, 2024)
Vecoplan, LLC v. United States
675 F. Supp. 3d 1263 (Court of International Trade, 2023)
ME Global, Inc. v. United States
633 F. Supp. 3d 1349 (Court of International Trade, 2023)
Chae v. Yellen
Federal Circuit, 2023
Starkist Co. v. United States
29 F.4th 1359 (Federal Circuit, 2022)
Target Gen. Merch., Inc. v. United States
392 F. Supp. 3d 1326 (Court of International Trade, 2019)
Streetsurfing LLC v. United States
11 F. Supp. 3d 1287 (Court of International Trade, 2014)
Grk Canada, Ltd. v. United States
761 F.3d 1354 (Federal Circuit, 2014)
Roche Vitamins, Inc. v. United States
922 F. Supp. 2d 1353 (Court of International Trade, 2013)
Kahrs International, Inc. v. United States
713 F.3d 640 (Federal Circuit, 2013)
CIBA VISION Corp. v. United States
2012 CIT 118 (Court of International Trade, 2012)
Pt Pindo Deli Pulp v. United States
825 F. Supp. 2d 1310 (Court of International Trade, 2012)
La Crosse Technology, Ltd. v. United States
826 F. Supp. 2d 1349 (Court of International Trade, 2012)
Estee Lauder, Inc. v. United States
815 F. Supp. 2d 1287 (Court of International Trade, 2012)
Applikon Biotechnology, Inc. v. United States
807 F. Supp. 2d 1323 (Court of International Trade, 2011)
Airflow Technology, Inc. v. United States
804 F. Supp. 2d 1292 (Court of International Trade, 2011)
The Container Store v. United States
2011 CIT 135 (Court of International Trade, 2011)
Container Store v. United States
800 F. Supp. 2d 1329 (Court of International Trade, 2011)
BASF Corp. v. United States
798 F. Supp. 2d 1353 (Court of International Trade, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
482 F.3d 1324, 28 I.T.R.D. (BNA) 2473, 2007 U.S. App. LEXIS 7216, Counsel Stack Legal Research, https://law.counselstack.com/opinion/basf-corporation-v-united-states-defendant-cross-cafc-2007.